ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Only a Small Proportion of Patients With Early-Stage Hodgkin Lymphoma May Potentially Benefit From Fluorodeoxyglucose-Positron Emission Tomography-Adapted Treatment Escalation.

Hugo J A Adams et al.PubMed ↗Publisher ↗

No numbers read from the abstract.